BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12548348)

  • 1. Modification of respiratory function parameters in patients with severe Parkinson's disease.
    De Pandis MF; Starace A; Stefanelli F; Marruzzo P; Meoli I; De Simone G; Prati R; Stocchi F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S69-70. PubMed ID: 12548348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Respiratory function impairment in patients with Parkinson's disease--a consideration on the possible pathogenetic relation to autonomic dysfunction].
    Yamada H; Murahashi M; Takahashi H; Kai K; Shibuya S; Jimi T; Wakayama Y; Yamada M
    Rinsho Shinkeigaku; 2000 Feb; 40(2):125-30. PubMed ID: 10835931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary functions in Parkinson's disease.
    Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
    Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale.
    Suzuki K; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Miyamoto T; Miyamoto M; Hirata K
    Mov Disord; 2007 Jul; 22(9):1245-51. PubMed ID: 17557325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
    Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
    Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression in patients with Parkinson's disease: impact on functioning.
    Stella F; Banzato CE; Barasnevicius Quagliato EM; Viana MA
    J Neurol Sci; 2008 Sep; 272(1-2):158-63. PubMed ID: 18589453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweating dysfunction in Parkinson's disease.
    Swinn L; Schrag A; Viswanathan R; Bloem BR; Lees A; Quinn N
    Mov Disord; 2003 Dec; 18(12):1459-63. PubMed ID: 14673882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.
    Forjaz MJ; Martinez-Martin P
    Mov Disord; 2006 Nov; 21(11):1892-8. PubMed ID: 16958134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.
    Elsinger CL; Rao SM; Zimbelman JL; Reynolds NC; Blindauer KA; Hoffmann RG
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1088-98. PubMed ID: 14738289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a pulmonary rehabilitation program on pulmonary function tests and exercise tolerance in patients with Parkinson's disease.
    Köseoğlu F; Inan L; Ozel S; Deviren SD; Karabiyikoğlu G; Yorgancioğlu R; Atasoy T; Oztürk A
    Funct Neurol; 1997; 12(6):319-25. PubMed ID: 9503194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper airway muscles dysfunction and levodopa responsiveness in Parkinson's disease.
    Brescia Morra V; Polverino M; De Luca G; Landi P; Galdi A; Campanella G
    Acta Neurol (Napoli); 1992; 14(4-6):512-8. PubMed ID: 1293993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pulmonary function in patients with ulcerative colitis.
    Mohamed-Hussein AA; Mohamed NA; Ibrahim ME
    Respir Med; 2007 May; 101(5):977-82. PubMed ID: 17049827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.